ESMO Clinical Practice Guidelines: Haematological Malignancies

The ESMO Clinical Practice Guidelines (CPG) are intended to provide the user with a set of recommendations for the best standards of cancer care, based on the findings of evidence-based medicine.

Latest enhanced and revised set of guidelines

ESMO has Clinical Practice Guidelines on the following Haematological Malignancies: Waldenstrom's macroglobulinaemia, Chronic myeloid leukaemia, Newly diagnosed and relapsed mantle cell lymphoma, Multiple myeloma, Newly diagnosed and relapsed follicular lymphoma, Extranodal diffuse large B-cell lymphoma and primary mediastinal B-cell lymphoma, Acute lymphoblastic leukaemia, Peripheral T-cell lymphomas, Diffuse large B cell lymphoma, Chronic lymphocytic leukaemia, Hairy cell leukaemia, Philadelphia chromosome-negative chronic myeloproliferative neoplasms, Myelodysplastic syndromes, Hodgkin lymphoma, Primary cutaneous lymphomas, Acute myeloblastic leukaemia in adult patients, Gastric marginal zone lymphoma of MALT type.

They include information on incidence, diagnosis, staging and risk assessment, treatment, response evaluation and follow-up.

Lymphomas , Rare Cancers

ESMO Consensus Conference: Marginal zone lymphoma, mantle cell lymphoma, peripheral T-cell lymphoma

Published in 2013 - Ann Oncol (2013) 24 (4): 857-877.
Authors: M. Dreyling, C. Thieblemont, A. Gallamini, L. Arcaini, E. Campo, O. Hermine, J. C. Kluin-Nelemans, M. Ladetto, S. Le Gouill, E. Iannitto, S. Pileri, J. Rodriguez, N. Schmitz, A. Wotherspoon, P. Zinzani, E. Zucca

view detailsof ESMO Consensus Conference: Marginal zone lymphoma, mantle cell lymphoma, peripheral T-cell lymphoma

Leukaemia

Chronic Lymphocytic Leukaemia: ESMO Clinical Practice Guidelines

Published in 2015 – Ann Oncol (2015) 26 (suppl 5): v78-v84.
Authors: B. Eichhorst, T. Robak, E. Montserrat, P. Ghia, P. Hillmen, M. Hallek, C. Buske

view detailsof Chronic Lymphocytic Leukaemia: ESMO Clinical Practice Guidelines

Leukaemia , Rare Cancers

Hairy Cell Leukaemia: ESMO Clinical Practice Guidelines

Published in 2015 – Ann Oncol (2015) 26 (suppl 5): v100-v107.

Authors: T. Robak, E. Matutes, D. Catovsky, P.L. Zinzani and C. Buske

view detailsof Hairy Cell Leukaemia: ESMO Clinical Practice Guidelines

Myeloproliferative Neoplasms , Rare Cancers

Philadelphia Chromosome-Negative Chronic Myeloproliferative Neoplasms: ESMO Clinical Practice Guidelines

Published in 2015 – Ann Oncol (2015) 26 (suppl 5): v85-v99.

Authors: A. M. Vannucchi, T. Barbui, F. Cervantes, C. Harrison, J.-J. Kiladjian, N. Kröger, J. Thiele and C. Buske

view detailsof Philadelphia Chromosome-Negative Chronic Myeloproliferative Neoplasms: ESMO Clinical Practice Guidelines

Lymphomas , Rare Cancers

Myelodysplastic Syndromes: ESMO Clinical Practice Guidelines

Published in 2014 – Ann Oncol (2014) 25 (suppl 3): iii57-iii69.

Authors: P. Fenaux, D. Haase, G. F. Sanz, V. Santini, C. Buske

view detailsof Myelodysplastic Syndromes: ESMO Clinical Practice Guidelines

Leukaemia , Rare Cancers

Acute Myeloblastic Leukaemia in Adult Patients: ESMO Clinical Practice Guidelines

Published in 2013 – Ann Oncol 2013; 24 (Suppl 6): vi138-vi143.

Authors: M.F. Fey, C. Buske

view detailsof Acute Myeloblastic Leukaemia in Adult Patients: ESMO Clinical Practice Guidelines

Lymphomas , Rare Cancers

Gastric Marginal Zone Lymphoma of MALT Type: ESMO Clinical Practice Guidelines

Published in 2013 – Ann Oncol 2013; 24 (Suppl 6): vi144-vi148.

Authors: E. Zucca, C. Copie-Bergman, U. Ricardi, C. Thieblemont, M. Raderer, M. Ladetto

view detailsof Gastric Marginal Zone Lymphoma of MALT Type: ESMO Clinical Practice Guidelines